M. Luckevich

发表

Bacterial disease resistance of transgenic hybrid poplar expressing the synthetic antimicrobial peptide D4E1.

A. Séguin, R. Mentag, M. Morency, 2003, Tree physiology.

Short‐term cost‐utility of degludec versus glargine U100 for patients with type 2 diabetes at high risk of hypoglycaemia and cardiovascular events: A Canadian setting (DEVOTE 9)

B. Zinman, S. Heller, T. Pieber, 2019, Diabetes, obesity & metabolism.

Understanding the risk of developing weight-related complications associated with different body mass index categories: a systematic review

C. L. le Roux, M. Luckevich, Adam Ben Taieb, 2022, Diabetology & Metabolic Syndrome.

Three-dimensional Structure of Myelin Basic Protein

G. Harauz, F. Ottensmeyer, D. Beniac, 1997, The Journal of Biological Chemistry.

Investigation on the induction of 14-3-3 in white spruce

A. Séguin, M. Luckevich, G. Lapointe, 2001, Plant Cell Reports.

Characterization of a dynamic S layer on Bacillus thuringiensis

T. Beveridge, M. Luckevich, 1989, Journal of bacteriology.

14-3-3 gene family in hybrid poplar and its involvement in tree defence against pathogens.

A. Séguin, M. Luckevich, G. Lapointe, 2001, Journal of experimental botany.

EE464 The Cost-Effectiveness of Subcutaneous Semaglutide 2.4MG Injection in the Management of Obesity in Canada Using the Core Obesity Model

M. Lamotte, M. Luckevich, AV Olivieri, 2022, Value in Health.

Treatment switch to nonacog beta pegol factor IX in hemophilia B: A Canadian cost-consequence analysis based on real-world factor IX consumption and clinical outcomes.

E. Iserman, F. Germini, A. Keepanasseril, 2023, Research and practice in thrombosis and haemostasis.

Hospitalization costs with degludec versus glargine U100 for patients with type 2 diabetes at high cardiovascular risk: Canadian costs applied to SAEs from a randomized outcomes trial

T. Pieber, J. Tarride, J. Gundgaard, 2021, Journal of medical economics.